AAPL325.89-1.85 (-0.56%) ▼|ABBV253.30-2.80 (-1.09%) ▼|ABT100.57+0.90 (+0.90%) ▲|ACN140.09-0.77 (-0.55%) ▼|ADBE218.36-8.80 (-3.87%) ▼|AMAT553.92-10.63 (-1.88%) ▼|AMD552.33+7.90 (+1.45%) ▲|AMGN366.05-0.19 (-0.05%) ▼|AMT166.06+2.67 (+1.63%) ▲|AMZN244.85-2.70 (-1.09%) ▼|AVGO396.81+10.31 (+2.67%) ▲|AXP348.74-2.05 (-0.58%) ▼|BA208.65+3.85 (+1.88%) ▲|BAC61.62+0.40 (+0.65%) ▲|BKNG177.86-1.54 (-0.86%) ▼|BLK1,056.63+18.39 (+1.77%) ▲|BMY60.76-0.17 (-0.28%) ▼|BNY160.39+1.50 (+0.94%) ▲|BRK-B489.39-0.26 (-0.05%) ▼|C132.25-0.59 (-0.44%) ▼|CAT889.31-0.66 (-0.07%) ▼|CL91.63+1.13 (+1.25%) ▲|CMCSA23.52-0.29 (-1.22%) ▼|COF201.36-4.86 (-2.36%) ▼|COP118.79+1.29 (+1.10%) ▲|COST927.31-1.91 (-0.21%) ▼|CRM163.00-7.06 (-4.15%) ▼|CSCO112.21+0.03 (+0.03%) ▲|CVS108.08-2.52 (-2.28%) ▼|CVX192.98+1.91 (+1.00%) ▲|DE607.33+20.45 (+3.48%) ▲|DHR179.14+0.13 (+0.07%) ▲|DIS95.87-0.27 (-0.28%) ▼|DUK127.95+2.04 (+1.62%) ▲|EMR139.63+0.37 (+0.27%) ▲|FDX321.02+5.83 (+1.85%) ▲|GD373.16+5.43 (+1.48%) ▲|GE341.19+0.49 (+0.14%) ▲|GEV985.03-93.78 (-8.69%) ▼|GILD130.34+0.06 (+0.05%) ▲|GM82.13+2.61 (+3.28%) ▲|GOOG341.91-4.28 (-1.24%) ▼|GOOGL342.09-5.06 (-1.46%) ▼|GS1,098.20+12.64 (+1.16%) ▲|HD331.45-0.15 (-0.05%) ▼|HON232.99+3.13 (+1.36%) ▲|IBM205.77-4.73 (-2.25%) ▼|INTC102.62-2.83 (-2.68%) ▼|INTU284.47-5.45 (-1.88%) ▼|ISRG340.69-9.37 (-2.68%) ▼|JNJ255.63+5.02 (+2.00%) ▲|JPM348.21+2.98 (+0.86%) ▲|KO82.20+0.23 (+0.28%) ▲|LIN508.67+3.64 (+0.72%) ▲|LLY1,163.01-12.40 (-1.06%) ▼|LMT514.36+7.27 (+1.43%) ▲|LOW204.35+2.09 (+1.03%) ▲|LRCX319.29-2.71 (-0.84%) ▼|MA531.98-6.32 (-1.17%) ▼|MCD263.57-0.34 (-0.13%) ▼|MDLZ60.86+1.00 (+1.67%) ▲|MDT81.89-0.46 (-0.56%) ▼|META627.17-16.64 (-2.58%) ▼|MMM170.76+0.00 (+0.00%) ▲|MO72.17-0.82 (-1.12%) ▼|MRK127.47+1.21 (+0.96%) ▲|MS218.50+2.10 (+0.97%) ▲|MSFT390.34-7.41 (-1.86%) ▼|MU959.48-11.34 (-1.17%) ▼|NEE89.41+1.48 (+1.68%) ▲|NFLX68.53-0.14 (-0.20%) ▼|NKE42.21-0.75 (-1.75%) ▼|NOW95.46-6.60 (-6.47%) ▼|NVDA212.06+4.77 (+2.30%) ▲|ORCL125.84-1.21 (-0.95%) ▼|PEP135.65+0.65 (+0.48%) ▲|PFE24.82-0.12 (-0.48%) ▼|PG149.13+1.03 (+0.70%) ▲|PLTR124.57-8.09 (-6.10%) ▼|PM194.30+6.26 (+3.33%) ▲|QCOM175.63+2.13 (+1.23%) ▲|RTX194.88+1.21 (+0.62%) ▲|SBUX103.98-0.47 (-0.45%) ▼|SCHW100.80+0.84 (+0.84%) ▲|SO95.80+1.95 (+2.08%) ▲|SPG226.22-0.57 (-0.25%) ▼|T23.04+0.78 (+3.50%) ▲|TMO526.46+3.00 (+0.57%) ▲|TMUS190.94+0.17 (+0.09%) ▲|TSLA374.01-4.92 (-1.30%) ▼|TXN294.19+2.89 (+0.99%) ▲|UBER70.33-1.22 (-1.71%) ▼|UNH431.31-5.04 (-1.16%) ▼|UNP292.56-0.57 (-0.19%) ▼|UPS115.84-0.50 (-0.43%) ▼|USB64.47+0.76 (+1.19%) ▲|V353.42-2.40 (-0.67%) ▼|VZ44.29+0.51 (+1.16%) ▲|WFC86.42-1.32 (-1.50%) ▼|WMT109.33-1.06 (-0.96%) ▼|XOM154.45+2.74 (+1.81%) ▲|AAPL325.89-1.85 (-0.56%) ▼|ABBV253.30-2.80 (-1.09%) ▼|ABT100.57+0.90 (+0.90%) ▲|ACN140.09-0.77 (-0.55%) ▼|ADBE218.36-8.80 (-3.87%) ▼|AMAT553.92-10.63 (-1.88%) ▼|AMD552.33+7.90 (+1.45%) ▲|AMGN366.05-0.19 (-0.05%) ▼|AMT166.06+2.67 (+1.63%) ▲|AMZN244.85-2.70 (-1.09%) ▼|AVGO396.81+10.31 (+2.67%) ▲|AXP348.74-2.05 (-0.58%) ▼|BA208.65+3.85 (+1.88%) ▲|BAC61.62+0.40 (+0.65%) ▲|BKNG177.86-1.54 (-0.86%) ▼|BLK1,056.63+18.39 (+1.77%) ▲|BMY60.76-0.17 (-0.28%) ▼|BNY160.39+1.50 (+0.94%) ▲|BRK-B489.39-0.26 (-0.05%) ▼|C132.25-0.59 (-0.44%) ▼|CAT889.31-0.66 (-0.07%) ▼|CL91.63+1.13 (+1.25%) ▲|CMCSA23.52-0.29 (-1.22%) ▼|COF201.36-4.86 (-2.36%) ▼|COP118.79+1.29 (+1.10%) ▲|COST927.31-1.91 (-0.21%) ▼|CRM163.00-7.06 (-4.15%) ▼|CSCO112.21+0.03 (+0.03%) ▲|CVS108.08-2.52 (-2.28%) ▼|CVX192.98+1.91 (+1.00%) ▲|DE607.33+20.45 (+3.48%) ▲|DHR179.14+0.13 (+0.07%) ▲|DIS95.87-0.27 (-0.28%) ▼|DUK127.95+2.04 (+1.62%) ▲|EMR139.63+0.37 (+0.27%) ▲|FDX321.02+5.83 (+1.85%) ▲|GD373.16+5.43 (+1.48%) ▲|GE341.19+0.49 (+0.14%) ▲|GEV985.03-93.78 (-8.69%) ▼|GILD130.34+0.06 (+0.05%) ▲|GM82.13+2.61 (+3.28%) ▲|GOOG341.91-4.28 (-1.24%) ▼|GOOGL342.09-5.06 (-1.46%) ▼|GS1,098.20+12.64 (+1.16%) ▲|HD331.45-0.15 (-0.05%) ▼|HON232.99+3.13 (+1.36%) ▲|IBM205.77-4.73 (-2.25%) ▼|INTC102.62-2.83 (-2.68%) ▼|INTU284.47-5.45 (-1.88%) ▼|ISRG340.69-9.37 (-2.68%) ▼|JNJ255.63+5.02 (+2.00%) ▲|JPM348.21+2.98 (+0.86%) ▲|KO82.20+0.23 (+0.28%) ▲|LIN508.67+3.64 (+0.72%) ▲|LLY1,163.01-12.40 (-1.06%) ▼|LMT514.36+7.27 (+1.43%) ▲|LOW204.35+2.09 (+1.03%) ▲|LRCX319.29-2.71 (-0.84%) ▼|MA531.98-6.32 (-1.17%) ▼|MCD263.57-0.34 (-0.13%) ▼|MDLZ60.86+1.00 (+1.67%) ▲|MDT81.89-0.46 (-0.56%) ▼|META627.17-16.64 (-2.58%) ▼|MMM170.76+0.00 (+0.00%) ▲|MO72.17-0.82 (-1.12%) ▼|MRK127.47+1.21 (+0.96%) ▲|MS218.50+2.10 (+0.97%) ▲|MSFT390.34-7.41 (-1.86%) ▼|MU959.48-11.34 (-1.17%) ▼|NEE89.41+1.48 (+1.68%) ▲|NFLX68.53-0.14 (-0.20%) ▼|NKE42.21-0.75 (-1.75%) ▼|NOW95.46-6.60 (-6.47%) ▼|NVDA212.06+4.77 (+2.30%) ▲|ORCL125.84-1.21 (-0.95%) ▼|PEP135.65+0.65 (+0.48%) ▲|PFE24.82-0.12 (-0.48%) ▼|PG149.13+1.03 (+0.70%) ▲|PLTR124.57-8.09 (-6.10%) ▼|PM194.30+6.26 (+3.33%) ▲|QCOM175.63+2.13 (+1.23%) ▲|RTX194.88+1.21 (+0.62%) ▲|SBUX103.98-0.47 (-0.45%) ▼|SCHW100.80+0.84 (+0.84%) ▲|SO95.80+1.95 (+2.08%) ▲|SPG226.22-0.57 (-0.25%) ▼|T23.04+0.78 (+3.50%) ▲|TMO526.46+3.00 (+0.57%) ▲|TMUS190.94+0.17 (+0.09%) ▲|TSLA374.01-4.92 (-1.30%) ▼|TXN294.19+2.89 (+0.99%) ▲|UBER70.33-1.22 (-1.71%) ▼|UNH431.31-5.04 (-1.16%) ▼|UNP292.56-0.57 (-0.19%) ▼|UPS115.84-0.50 (-0.43%) ▼|USB64.47+0.76 (+1.19%) ▲|V353.42-2.40 (-0.67%) ▼|VZ44.29+0.51 (+1.16%) ▲|WFC86.42-1.32 (-1.50%) ▼|WMT109.33-1.06 (-0.96%) ▼|XOM154.45+2.74 (+1.81%) ▲|
24.9 C
New York
Thursday, July 23, 2026

Tag: thresholds

newssourceFORcompanyinformationcontent1releasesmarket

Prenetics’ IM8 Secures $1 Billion Growth Financing from General Catalyst’s Customer Value Fund (CVF)

Prenetics’ IM8 Secures $1 Billion Growth Financing from General Catalyst’s Customer Value Fund (CVF)

Nextensa NV/SA: Information on the total number of voting rights and shares

PRESS RELEASE

Budgyt Urges Nonprofits to Move From Annual Budgets to Live Financial Plans

Budgyt makes the case for live nonprofit financial planning, with rolling forecasts and grant-aware allocation that update as funding changes. From $399/mo

Monopar Presents New Analyses of Phase 3 FoCus Data at EAN 2026 Showing Greater Neurologic and Global Clinical Benefit with ALXN1840 Versus Standard of...

WILMETTE, Ill., June 26, 2026 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (“Monopar” or the “Company”) (Nasdaq: MNPR), a clinical-stage biopharmaceutical company developing innovative treatments for patients with unmet medical needs, today announced that new analyses from the Phase 3 FoCus randomized controlled clinical trial of ALXN1840 (tiomolibdate choline, TMC) will be presented at the 12th Congress of the European Academy of Neurology (EAN 2026), June 27–30, 2026, in Geneva, Switzerland. These analyses build upon the previously reported Phase 3 FoCus results demonstrating ALXN1840 met its primary endpoint of superior copper mobilization versus standard of care.

THCA Flower for Sale: Exhale Wellness Expands Online Availability with New Exotic Indoor Strains for 2026

THCA flower for sale at Exhale Wellness: shop new exotic indoor-grown strains for 2026, lab-tested and Farm Bill-compliant. Buy premium hemp buds online.

NEVADA KING GRADUATES TO THE PREMIUM OTCQX BEST MARKET, ENHANCING VISIBILITY FOR U.S. INVESTORS

VANCOUVER, BC, June 26, 2026 /PRNewswire/ - Nevada King Gold Corp. (TSXV: NKG) (OTCQX: NKGFF) ("Nevada King" or the "Company") is pleased to announce that...

NEVADA KING GRADUATES TO THE PREMIUM OTCQX BEST MARKET, ENHANCING VISIBILITY FOR U.S. INVESTORS

VANCOUVER, BC, June 26, 2026 /CNW/ - Nevada King Gold Corp. (TSXV: NKG) (OTCQX: NKGFF) ("Nevada King" or the "Company") is pleased to announce that...

DecisionDx®-Melanoma’s i31-SLNB Outperforms MIA Nomogram in Identifying Patients Who May Safely Forgo Sentinel Lymph Node Biopsy

Newly published prospective study shows DecisionDx-Melanoma's i31-SLNB test result more accurately identifies patients at low and high risk of sentinel lymph node (SLN) positivity...

Vascarta Announces Phase I Results of VAS-101 Administered Sublingually in Sickle Cell Disease Patients

SUMMIT, N.J., June 24, 2026 /PRNewswire/ -- Vascarta Inc., a clinical-stage biopharmaceutical company advancing innovative treatments for pain and inflammation, announced today the successful...

OBM Launches Foreman Intelligence to Deliver Fleet-Wide Analytics and AI-Powered Insights for Bitcoin Mining Operations

New platform helps operators connect performance, maintenance, inventory, and energy market data to improve profitability 
New platform helps operators connect performance, maintenance, inventory, and energy market data to improve profitability

Budgyt Clarifies the Difference Between Budgeting and Accounting Software for Nonprofits

Budgyt explains budgeting vs accounting software: accounting records the past, budgeting plans the future, and how the two work together for nonprofits.

Rock Tech Lithium Expands Made-in-Ontario Lithium Supply Chain with Strategic Acquisition of Victory Project

High-grade spodumene occurrences strategically located near Trans-Canada Highway, CPKC rail, and power infrastructure adds potential feedstock opportunity for Rock Tech's Ontario mine-to-converter platform, linking...

Budgyt Frames Grant Allocation and Audit Readiness as the Core of Nonprofit Grant Budgeting

Budgyt shares new guidance on grant budgeting software, helping nonprofits allocate payroll across grants, track restricted funds, and stay audit-ready.

IUX Releases Educational Analysis on How Economic Volatility May Influence Force Sell Risk in Leveraged Trading

EBENE CYBERCITY, Mauritius, June 19, 2026 (GLOBE NEWSWIRE) -- IUX has released an educational analysis examining how periods of heightened economic volatility, particularly following major macroeconomic announcements, may influence Force Sell risk in leveraged trading. The publication comes as recent economic data releases have once again highlighted the impact that unexpected market movements can have on leveraged positions when outcomes diverge significantly from market expectations.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsThresholds

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers